Scientists have identified the protein complex that gives the hepatitis C virus the ability to bind and infect cells.

The tremendous activity in anti-HCV drug development needs to be extended to HCV vaccine development. Continued research activities to provide further insights into the mechanisms of HCV clearance ...

British drugmaker GSK said on Wednesday administration of its respiratory syncytial virus (RSV) vaccine and shingles shot ...

reactogenicity and safety of Arexvy (Respiratory Syncytial Virus Vaccine) when co-administered with Shingrix (Zoster Vaccine). Shingrix is approved to prevent shingles (herpes zoster) in adults ...

This gap, Grove argues, has slowed the development of an effective vaccine against hepatitis C, which kills hundreds of thousands of people each year. Could AI-designed proteins be weaponized?

Findings showed a noninferior immune response for both vaccines when Shingrix and Arexvy were coadministered compared with separate administration (primary endpoint). Both anti-gE antibody ...

The remaining half are used for the treatment of HBV, herpes simplex virus (HSV), varicella-zoster virus (VZV), cytomegalovirus (CMV), influenza and HCV infections. For the antiviral drugs ...

With sales of its flagship shingles vaccine Shingrix separately faltering, new data on co-administration of the two adult vaccines could provide a new way for the company to promote the jabs.

The P.E.I. government has lowered the age requirement for a free shingles vaccine to 50. The change from age 60 was announced in a news release Monday morning and is effective immediately.